NCT00524641已完成不适用
A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort® as Maintenance and Relief Therapy in a Single Inhaler (Symbicort® SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,254
- 试验地点
- 1
研究概览
简要总结
To investigate the change in patient's asthma symptom control using ACQ scores after 4 to 6 weeks of Symbicort Turbuhaler (budesonide/ formoterol) in SMART approach.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Asthma patients from both sexes, age 18 or older
- •Have already been on Symbicort SMART treatment
- •Willing to give written informed consents to participate in the program.
排除标准
- •Patients who are not willing to give written informed consent
- •Patients in emergency care for asthma at ICUs or COPD patients are excluded from the program.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life ConditionsAsthmaNCT04184284AstraZeneca246
终止
不适用
A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe AsthmaticsAsthmaNCT02270827Royal Brompton & Harefield NHS Foundation Trust5
撤回
不适用
An Observational Prospective Study to Characterize Patients Initiating Enerzair® Breezhaler®, With or Without Sensor, as a Maintenance Treatment for AsthmaAsthmaNCT05120986Novartis Pharmaceuticals
已完成
不适用
Real-world Effectiveness of Combination Therapy in AsthmaAsthmaNCT01141465Research in Real-Life Ltd815,377
已完成
不适用
Interventions To Help Asthma Clinical AdherenceAsthma in ChildrenHumansHispanic AmericansChildNCT02999789University of California, San Francisco13